Evidence map›Paper›PMID 36985785›Full record

ArticleMolecules (Basel, Switzerland)2023

Graphene@Curcumin-Copper Paintable Coatings for the Prevention of Nosocomial Microbial Infection.

Mohammad Oves, Mohammad Omaish Ansari, Mohammad Shahnawaze Ansari, Adnan Memić

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Synthesis of Graphene@CPharmaceutical nanotechnology · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohammad OvesCenter of Excellence in Environmental Studies, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-8513-6155
Mohammad Omaish AnsariCenter of Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-7603-5870
Mohammad Shahnawaze AnsariCenter of Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Adnan MemićCenter of Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-4639-8168
King Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of antimicrobial resistance has brought into focus the urgent need for the next generation of antimicrobial coating. Specifically, the coating of suitable antimicrobial nanomaterials on contact surfaces seems to be an effective method for the disinfection/contact killing of microorganisms. In this study, the antimicrobial coatings of graphene@curcumin-copper (GN@CR-Cu) were prepared using a chemical synthesis methodology. Thus, the prepared GN@CR-Cu slurry was successfully coated on different contact surfaces, and subsequently, the GO in the composite was reduced to graphene (GN) by low-temperature heating/sunlight exposure. Scanning electron microscopy was used to characterize the coated GN@CR-Cu for the coating properties, X-ray photon scattering were used for structural characterization and material confirmation. From the morphological analysis, it was seen that CR and Cu were uniformly distributed throughout the GN network. The nanocomposite coating showed antimicrobial properties by contact-killing mechanisms, which was confirmed by zone inhibition and scanning electron microscopy. The materials showed maximum antibacterial activity against

Indexed as

Anti-Infective AgentsCross InfectionCurcuminGraphiteAnti-Bacterial AgentsCoated Materials, BiocompatibleCopperEscherichia coliHumansAnti-Bacterial AgentsAnti-Infective AgentsCoated Materials, BiocompatibleCopperCurcuminGraphiteantimicrobialcoatingcoppercurcuminE. coligraphenePseudomonas aeruginosa

Identifiers

PMID36985785
PMCPMC10051306
OpenAlexW4328117119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.